168 related articles for article (PubMed ID: 27470584)
1. Alpha-synuclein and beta-amyloid - different targets, same players: calcium, free radicals and mitochondria in the mechanism of neurodegeneration.
Angelova PR; Abramov AY
Biochem Biophys Res Commun; 2017 Feb; 483(4):1110-1115. PubMed ID: 27470584
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β, α-synuclein and the c subunit of the ATP synthase: Can these peptides reveal an amyloidogenic pathway of the permeability transition pore?
Amodeo GF; Pavlov EV
Biochim Biophys Acta Biomembr; 2021 Mar; 1863(3):183531. PubMed ID: 33309700
[TBL] [Abstract][Full Text] [Related]
3. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
4. Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies.
Lautenschläger J; Wagner-Valladolid S; Stephens AD; Fernández-Villegas A; Hockings C; Mishra A; Manton JD; Fantham MJ; Lu M; Rees EJ; Kaminski CF; Kaminski Schierle GS
J Biol Chem; 2020 Jul; 295(30):10138-10152. PubMed ID: 32385113
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols.
Camilleri A; Zarb C; Caruana M; Ostermeier U; Ghio S; Högen T; Schmidt F; Giese A; Vassallo N
Biochim Biophys Acta; 2013 Nov; 1828(11):2532-43. PubMed ID: 23817009
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.
Briston T; Hicks AR
Biochem Soc Trans; 2018 Aug; 46(4):829-842. PubMed ID: 29986938
[TBL] [Abstract][Full Text] [Related]
7. Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synuclein.
Di Scala C; Yahi N; Boutemeur S; Flores A; Rodriguez L; Chahinian H; Fantini J
Sci Rep; 2016 Jun; 6():28781. PubMed ID: 27352802
[TBL] [Abstract][Full Text] [Related]
8. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.
Forloni G; Artuso V; La Vitola P; Balducci C
Mov Disord; 2016 Jun; 31(6):771-81. PubMed ID: 27030592
[TBL] [Abstract][Full Text] [Related]
9. Radicicol rescues yeast cell death triggered by expression of human α-synuclein and its A53T mutant, but not by human βA4 peptide and proapoptotic protein bax.
Derf A; Verekar SA; Jain SK; Deshmukh SK; Bharate SB; Chaudhuri B
Bioorg Chem; 2019 Apr; 85():152-158. PubMed ID: 30612081
[TBL] [Abstract][Full Text] [Related]
10. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders.
Abramov AY; Berezhnov AV; Fedotova EI; Zinchenko VP; Dolgacheva LP
Biochem Soc Trans; 2017 Aug; 45(4):1025-1033. PubMed ID: 28733489
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases.
Alexiou A; Nizami B; Khan FI; Soursou G; Vairaktarakis C; Chatzichronis S; Tsiamis V; Manztavinos V; Yarla NS; Md Ashraf G
Curr Protein Pept Sci; 2018; 19(9):850-857. PubMed ID: 28799502
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.
Bir A; Sen O; Anand S; Khemka VK; Banerjee P; Cappai R; Sahoo A; Chakrabarti S
J Neurochem; 2014 Dec; 131(6):868-77. PubMed ID: 25319443
[TBL] [Abstract][Full Text] [Related]
13. V63 and N65 of overexpressed α-synuclein are involved in mitochondrial dysfunction.
Zhang H; Liu J; Wang X; Duan C; Wang X; Yang H
Brain Res; 2016 Jul; 1642():308-318. PubMed ID: 27048753
[TBL] [Abstract][Full Text] [Related]
14. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
Williams SM; Schulz P; Sierks MR
Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial degradation of amyloidogenic proteins - A new perspective for neurodegenerative diseases.
Lautenschäger J; Kaminski Schierle GS
Prog Neurobiol; 2019 Oct; 181():101660. PubMed ID: 31301323
[TBL] [Abstract][Full Text] [Related]
16. Hsp27 suppresses the Cu(2+)-induced amyloidogenicity, redox activity, and cytotoxicity of α-synuclein by metal ion stripping.
Asthana A; Bollapalli M; Tangirala R; Bakthisaran R; Mohan Rao Ch
Free Radic Biol Med; 2014 Jul; 72():176-90. PubMed ID: 24746619
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β and α-Synuclein Decrease the Level of Metal-Catalyzed Reactive Oxygen Species by Radical Scavenging and Redox Silencing.
Pedersen JT; Chen SW; Borg CB; Ness S; Bahl JM; Heegaard NH; Dobson CM; Hemmingsen L; Cremades N; Teilum K
J Am Chem Soc; 2016 Mar; 138(12):3966-9. PubMed ID: 26967463
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
Kazmierczak A; Strosznajder JB; Adamczyk A
Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β suppresses AMP-activated protein kinase (AMPK) signaling and contributes to α-synuclein-induced cytotoxicity.
Lin CL; Cheng YS; Li HH; Chiu PY; Chang YT; Ho YJ; Lai TJ
Exp Neurol; 2016 Jan; 275 Pt 1():84-98. PubMed ID: 26515689
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein amino terminus regulates mitochondrial membrane permeability.
Shen J; Du T; Wang X; Duan C; Gao G; Zhang J; Lu L; Yang H
Brain Res; 2014 Dec; 1591():14-26. PubMed ID: 25446002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
